布瓦西坦 杂质 162
Brivaracetam impurity 162
产品编号 :
MDL No. :
分子式 :
分子量 :
Cas No. :
| 包装规格 | 交货周期 | 质量标准 | 品牌 | 目录价 |
|---|---|---|---|---|
|
抱歉，暂无牌价信息 |
||||
基础信息
| Inchi | InChI=1S/C21H40N2O3/c1-6-8-16(13-23-18(7-2)21(22)25)12-20(24)26-19-11-15(5)9-10-17(19)14(3)4/h14-19,23H,6-13H2,1-5H3,(H2,22,25)/t15-,16?,17+,18+,19-/m1/s1 |
|---|---|
| GHS | |
| Smiles | CCCC(CC(=O)O[C@@H]1C[C@H](C)CC[C@H]1C(C)C)CN[C@H](C(=O)N)CC |
| 化学稳定性 | |
| 沸点 | |
| 密度 | |
| 海关编码 | |
| 手性 | |
| 生物活性 | |
| InchiKey | YIXNNNCLIPUFPE-QBPKKDFKSA-N |
| 别名 | |
| 性状 | |
| 存储条件 | |
| 熔点 | |
| 闪点 | |
| 特性 | |
| 用途 | |
| 理化性质 | |
| UN No. | |
| 蒸气压 | |
| 运输要求 | |
| 品牌 |
安全信息
| 水溶解性 | |
|---|---|
| 危险品分类 | |
| 危险品标志 | |
| 有害分解物 | |
| 安全说明 | |
| 存储要求 | |
| 信号词 |
浏览记录
![N-(4'-(9-(dibenzo[b,d]thiophen-4-yl)-13c-methyl-9,13c-dihydro-5H-indolo[3',2':4,5]cyclopenta[1,2,3-kl]acridin-5-yl)-[1,1'-biphenyl]-4-yl)-N-phenylphenanthren-9-amine](/image/product/90078044.png?ts=1769783239)
![N-(4'-(4H-4,8b-diazaindeno[1,2,3-gh]pleiaden-4-yl)-[1,1'-biphenyl]-4-yl)-N-([1,1'-biphenyl]-4-yl)-9-(naphthalen-2-yl)-9H-carbazol-2-amine](/image/product/30077256.png?ts=1769783228)
![N-(4'-(4H-4,8b-diazaindeno[1,2,3-gh]pleiaden-4-yl)-[1,1'-biphenyl]-4-yl)-N-([1,1'-biphenyl]-4-yl)-5,5-dimethyl-5H-dibenzo[b,d]silol-2-amine](/image/product/60077361.png?ts=1769783227)
![N-(4'-(4H-4,8b-diazaindeno[1,2,3-gh]pleiaden-4-yl)-[1,1'-biphenyl]-4-yl)-N-([1,1'-biphenyl]-2-yl)spiro[fluorene-9,9'-thioxanthen]-4-amine](/image/product/90077711.png?ts=1769783227)
![(8S,13S,14S,17R)-13-methyl-17-((E)-2-(tributylstannyl)vinyl)-1,2,4,6,7,8,12,13,14,15,16,17-dodecahydrospiro[cyclopenta[a]phenanthrene-3,2'-[1,3]dioxolan]-17-ol](/image/product/80067448.png?ts=1758589869)
![(2R,4aR,6S,7R,10aS,Z)-2-phenyl-6-vinyl-4,4a,6,7,8,10a-hexahydro-[1,3]dioxino[5,4-b]oxocin-7-yl 2-((2R,3R,4R,4aS,9aS)-4-(naphthalen-2-ylmethoxy)-3-(((Z)-3-(tributylstannyl)allyl)oxy)-3,4,4a,6,9,9a-hexahydro-2H-pyrano[3,2-b]oxepin-2-yl)acetate](/image/product/90067406.png?ts=1758589841)
![5-((tributylstannyl)methyl)dodecahydro-1H-indolo[7a,1-a]isoquinoline-1,6(2H)-dione](/image/product/20067280.png?ts=1758589829)
![(E)-4,4'-bis(11-(1,1,1,3,5,5,5-heptamethyltrisiloxan-3-yl)undecyl)-2,2'-bis(trimethylstannyl)-[6,6'-bithieno[3,2-b]pyrrolylidene]-5,5'(4H,4'H)-dione](/image/product/80067424.png?ts=1758589828)
![(6S,10S)-12-((S,E)-4-(tributylstannyl)but-3-en-2-yl)-7,8,10,11-tetrahydro-5H-6,10-epiminocycloocta[b]indol-9(6H)-one](/image/product/40067063.png?ts=1758589824)
![6-(benzyloxy)-5-(tributylstannyl)tetrahydrofuro[3,2-b]furan-2(5H)-one](/image/product/20067277.png?ts=1758589824)
![(6S,10S)-12-((S)-3-(tributylstannyl)but-3-en-2-yl)-7,8,10,11-tetrahydro-5H-6,10-epiminocycloocta[b]indol-9(6H)-one](/image/product/80067423.png?ts=1758589824)
![tributyl((Z)-3-((3aR,5R,5aS,8aS,8bR)-2,2,7,7-tetramethyltetrahydro-3aH-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-5-yl)allyl)stannane](/image/product/60067232.png?ts=1758589821)
![tributyl((R,E)-3-methoxy-3-((3aR,5R,5aS,8aS,8bR)-2,2,7,7-tetramethyltetrahydro-3aH-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-5-yl)prop-1-en-1-yl)stannane](/image/product/10067726.png?ts=1758589816)
